sponsored by VMware, Inc.
Posted:  18 Jun 2007
Published:  01 Jan 2006
Format:  PDF
Length:  4  Page(s)
Type:  Case Study
Language:  English
Solvay Pharmaceuticals, Inc. is the U.S. subsidiary of the research driven group of pharmaceutical companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology and men's and women's health.

In this case study learn how the implementation of VMware infrastructure increased scalability and performance in the datacenter. As a result, Solvay Pharmaceuticals:

  • Saved more than $1.5 million in hardware costs
  • Decreased paperwork and server procurement costs
  • Achieved server consolidation ratio of 10:1
  • Increased CPU utilization from 0-5 percent to 15-25 percent
  • Facilitated server management with VirtualCenter; four people manage more than 100 servers
  • Decreased server deployment time from 6 hours to 30 minutes
  • Achieved 585 days of continuous uptime

Application Deployment | Microprocessors | Network Performance | Pharmaceutical Industry | Server Consolidation | Server Virtualization | VMware

View All Resources sponsored by VMware, Inc.

About TechTarget:

TechTarget provides enterprise IT professionals with the information they need to perform their jobs - from developing strategy, to making cost-effective IT purchase decisions and managing their organizations' IT projects - with its network of technology-specific Web sites, events and magazines

All Rights Reserved, Copyright 2000 - 2014, TechTarget | Read our Privacy Statement